Literature DB >> 32343394

Examining Older Adult Cognitive Status in the Time of COVID-19.

Nathan C Hantke1,2, Christine Gould3,4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32343394      PMCID: PMC7267336          DOI: 10.1111/jgs.16514

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


× No keyword cloud information.
To the Editor: The rapid onset of the coronavirus disease 2019 (COVID‐19) pandemic has left many providers ill equipped to continue to provide care as usual. As older adults are particularly at risk for mortality with COVID‐19, most providers have rightly pivoted to clinical care via telephone and virtual video visits. Recent research suggests older adults are open to the idea of virtual visits, often preferring them as compared to face‐to‐face appointments for specialty mental health and dementia care. However, not all clinical services are easily translated into a virtual environment (eg, cognitive assessment), resulting in providers either utilizing creativity or foregoing clinical tools during the health crisis. This letter briefly reviews the current state of remote cognitive assessment, with the goal of outlining appropriate clinical measures for older adults. The present most popular methods of cognitive assessment often do not lend themselves well to virtual visits, as they require hands‐on manipulation of stimuli or carefully standardized administration of visual material. The process of creating psychometrically sound tests or translating a test across modalities is unfortunately a cumbersome process. Several studies have examined intraclass correlation coefficients (ICCs) between virtual and face‐to‐face visits for select neuropsychological measures, suggesting these measurements are reliable across modalities1, 2 and show good criterion validity. But, teleneuropsychological research has primarily focused on providing services to rural patients via video teleconference from a primary medical center to a rural clinic. Providing services directly to a patientʼs home introduces multiple latent variables that may be detrimental to construct validity, and makes extrapolating extant research to home‐based virtual visits complicated. Adequate internet connection speeds, camera quality, privacy, and access to a distraction‐free environment may contribute to variability in assessment when conducted to the home rather than from clinic to clinic. While teleneuropsychological assessment is increasingly showing clinical potential, providers may wish to be mindful of its strengths, limitations, and appropriate uses for brief cognitive assessment. Traditional cognitive screeners have also shown promise for translation into a video modality. Measures, such as the Mini‐Mental State Examination (MMSE) and common mental health questionnaires such as the Geriatric Depression Scale, appear to be diagnostically comparable to in‐person clinical visits. Mildly modified administration of the Montreal Cognitive Assessment (MoCA) has shown high ICC, and there is an audio‐visual version of the MoCA now available online, modified for telehealth administration (Table 1). Versions of the MoCA for older adults with hearing and vision impairment are in development as well.
Table 1

Summary of Telemedicine Cognitive Measures

MeasureScoresRecommended ModalityConvergence With In‐Person Assessments
Brief Test of Adult Cognition a Six subscale z‐scores create composite scoreTelephone or videoConvergent validity with neuropsychology assessment 9
Cognitive Telephone Screening InstrumentSix weighted subtest scoresTelephone or videoConvergent validity with MMSE 8
MMSE0 to 30VideoICC = 0.91 2
MoCA‐Telehealth0 to 30VideoICC = 0.93 5
MoCA‐Telephone0 to 22Telephone or videoComparable to TICS 10
TICS0 to 41Telephone or videoConvergent validity with MMSE, with T‐scores available for direct comparison 7

Abbreviations: ICC, intraclass correlation coefficient; MMSE, Mini‐Mental State Examination; MoCA, Montreal Cognitive Assessment; TICS, Telephone Interview for Cognitive Status.

This measure is presently for research purposes only.

Summary of Telemedicine Cognitive Measures Abbreviations: ICC, intraclass correlation coefficient; MMSE, Mini‐Mental State Examination; MoCA, Montreal Cognitive Assessment; TICS, Telephone Interview for Cognitive Status. This measure is presently for research purposes only. Beyond cognitive measures modified for video‐based administration, telephone‐based cognitive assessment has a rich research history and is more likely to be designed initially for the telephone modality, as compared to translated from in‐person normative data. The Telephone Interview for Cognitive Status is appropriate for older adults, aged 60 to 98 years, takes approximately 10 minutes, and shows strong correlation with the MMSE. Another measure, the Cognitive Telephone Screening Instrument, contains six subtests assessing multiple cognitive domains and shows good convergent validity with the MMSE. There is also a modified version of the MoCA available that is appropriate for telephone use. The Brief Test of Adult Cognition provides a comparatively more extensive assessment, taking 20 minutes and showing good construct and concurrent validity with traditional neuropsychological measures, but is presently only available for research purposes. This measure also prompts the assessor to conduct a brief test regarding hearing by repeating a series of five numbers before beginning, which could be adapted for any telephone‐based measure. Despite the limitations of providing healthcare during the COVID‐19 pandemic, providers of older adult care have several options for assessing cognitive status to supplement a clinical interview. Extant measures range from modified traditional screeners to neuropsychological batteries assessing multiple cognitive domains, albeit in a limited fashion. The sudden transition to an entirely telemedicine healthcare system was jarring for most providers, and it appears likely the COVID‐19 pandemic will permanently alter healthcare in some capacity. At present, the remote assessment of cognition primarily consists of traditional measures “shoe horned” into a video modality for screening purposes, and not likely to replace more extensive in‐person assessment. Yet, the healthcare professionals privileged with providing care to older adults may increasingly be called on to provide telemedicine‐based services in the future. Increased competence in technology‐mediated healthcare and the construction of telehealth‐based cognitive measures will likely become imperative moving forward. Future research designing cognitive measures that utilize and embrace the strengths of telehealth will become vital within the changing landscape of our healthcare systems.
  8 in total

1.  Development and validation of the Cognitive Telephone Screening Instrument (COGTEL) for the assessment of cognitive function across adulthood.

Authors:  Matthias Kliegel; Mike Martin; Theodor Jäger
Journal:  J Psychol       Date:  2007-03

2.  Dementia Care Comes Home: Patient and Caregiver Assessment via Telemedicine.

Authors:  Allison Lindauer; Adriana Seelye; Bayard Lyons; Hiroko H Dodge; Nora Mattek; Katherine Mincks; Jeffrey Kaye; Deniz Erten-Lyons
Journal:  Gerontologist       Date:  2017-10-01

Review 3.  Neuropsychological Test Administration by Videoconference: A Systematic Review and Meta-Analysis.

Authors:  Timothy W Brearly; Robert D Shura; Sarah L Martindale; Rory A Lazowski; David D Luxton; Brian V Shenal; Jared A Rowland
Journal:  Neuropsychol Rev       Date:  2017-06-16       Impact factor: 7.444

4.  Teleneuropsychology: evidence for video teleconference-based neuropsychological assessment.

Authors:  C Munro Cullum; L S Hynan; M Grosch; M Parikh; M F Weiner
Journal:  J Int Neuropsychol Soc       Date:  2014-10-24       Impact factor: 2.892

5.  Development of a telemedicine protocol for the diagnosis of Alzheimer's disease.

Authors:  Poh-Kooi Loh; Mark Donaldson; Leon Flicker; Sean Maher; Peter Goldswain
Journal:  J Telemed Telecare       Date:  2007       Impact factor: 6.184

6.  Monitoring cognitive functioning: psychometric properties of the brief test of adult cognition by telephone.

Authors:  Margie E Lachman; Stefan Agrigoroaei; Patricia A Tun; Suzanne L Weaver
Journal:  Assessment       Date:  2013-12-09

7.  Validity of Teleneuropsychological Assessment in Older Patients with Cognitive Disorders.

Authors:  Hannah E Wadsworth; Kaltra Dhima; Kyle B Womack; John Hart; Myron F Weiner; Linda S Hynan; C Munro Cullum
Journal:  Arch Clin Neuropsychol       Date:  2018-12-01       Impact factor: 2.813

8.  Telephone assessment of cognition after transient ischemic attack and stroke: modified telephone interview of cognitive status and telephone Montreal Cognitive Assessment versus face-to-face Montreal Cognitive Assessment and neuropsychological battery.

Authors:  Sarah T Pendlebury; Sarah J V Welch; Fiona C Cuthbertson; Jose Mariz; Ziyah Mehta; Peter M Rothwell
Journal:  Stroke       Date:  2012-11-08       Impact factor: 7.914

  8 in total
  15 in total

1.  Malignant Pleural Effusion Management.

Authors:  Lucía Ferreiro; Juan Suárez-Antelo; Luis Valdés
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2020-07-02       Impact factor: 4.872

2.  Functional Limitations Post-COVID-19: A Comprehensive Assessment Strategy.

Authors:  Rodrigo Torres-Castro; Lilian Solis-Navarro; Mercè Sitjà-Rabert; Jordi Vilaró
Journal:  Arch Bronconeumol       Date:  2020-08-28       Impact factor: 4.872

3.  Preliminary Findings from a Telephone-Based Cognitive Screening of an Adult HIV Research Cohort during the COVID-19 Pandemic.

Authors:  Jairo A Gonzalez; Uraina S Clark; Desiree Byrd; Yusuf Clarke; Kaitlyn Greenwood; Elizabeth Tell; Cira Carrion-Park; Maria Pizzirusso; Rhonda Burgess; Susan Morgello
Journal:  Arch Clin Neuropsychol       Date:  2022-07-02       Impact factor: 3.448

4.  From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery.

Authors:  Montserrat Alegret; Ana Espinosa; Gemma Ortega; Alba Pérez-Cordón; Ángela Sanabria; Isabel Hernández; Marta Marquié; Maitée Rosende-Roca; Ana Mauleón; Carla Abdelnour; Liliana Vargas; Ester Esteban de Antonio; Rogelio López-Cuevas; Juan Pablo Tartari; Emilio Alarcón-Martín; Lluís Tárraga; Agustín Ruiz; Mercè Boada; Sergi Valero
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

5.  Pilot Study to Assess the Feasibility of a Mobile Unit for Remote Cognitive Screening of Isolated Elderly in Rural Areas.

Authors:  Radia Zeghari; Rachid Guerchouche; Minh Tran Duc; François Bremond; Maria Pascale Lemoine; Vincent Bultingaire; Kai Langel; Zeger De Groote; Francis Kuhn; Emmanuelle Martin; Philippe Robert; Alexandra König
Journal:  Int J Environ Res Public Health       Date:  2021-06-05       Impact factor: 3.390

6.  Convergent Validity of In-Person Assessment of Inpatients With Traumatic Brain Injury Using the Brief Test of Adult Cognition by Telephone (BTACT).

Authors:  Christina A DiBlasio; Thomas A Novack; Edwin W Cook; Kristen Dams-O'Connor; Richard E Kennedy
Journal:  J Head Trauma Rehabil       Date:  2021 Jul-Aug 01       Impact factor: 3.117

7.  The Strategies for Quantitative and Qualitative Remote Data Collection: Lessons From the COVID-19 Pandemic.

Authors:  Keenae Tiersma; Mira Reichman; Paula J Popok; Zoe Nelson; Maura Barry; A Rani Elwy; Efrén J Flores; Kelly E Irwin; Ana-Maria Vranceanu
Journal:  JMIR Form Res       Date:  2022-04-08

8.  Mental Health Care of Older Adults during Coronavirus Disease (COVID-19) Pandemic: Challenges and Way ahead in India.

Authors:  Shiva Shanker Reddy Mukku; Palanimuthu Thangaraju T Sivakumar
Journal:  Indian J Psychol Med       Date:  2020-08-16

Review 9. 

Authors:  Paula J Gosse; Charles D Kassardjian; Mario Masellis; Sara B Mitchell
Journal:  CMAJ       Date:  2021-06-07       Impact factor: 8.262

10.  Environmental Distractions during Unsupervised Remote Digital Cognitive Assessment.

Authors:  E N Madero; J Anderson; N T Bott; A Hall; D Newton; N Fuseya; J E Harrison; J R Myers; J M Glenn
Journal:  J Prev Alzheimers Dis       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.